Video

Emily Johnston Discusses End-of-Life Care for Younger Patients

Emily Johnston, hematology/oncology fellow at the Lucile Packard Children's Hospital Stanford, discusses intensity of end-of-life care for the adolescent and young adult (AYA) cancer population.

Emily Johnston, hematology/oncology fellow at the Lucile Packard Children's Hospital Stanford, discusses intensity of end-of-life care for the adolescent and young adult (AYA) cancer population.

Most AYA patients involved in a study conducted at Lucile Packard Children's Hospital received at least one intensive end-of-life intervention, but statistics were not same across different populations. Johnston found that minorities received more end-of-life interventions than whites did, and patients who were not treated at a speciality hospital also had higher incidences of interventions.

Related Videos
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with brown and grey hair.
Image of man with grey hair.
Image of bald man in suit.
Related Content